Machine signal
Active cluster sell — 9 distinct insiders, $59.1M, window ends Oct 2, 2026.
Figures computed from official regulatory filings — .
Analysttarget 141 USD (+16%) · consensus 4/5 · 4 buy · 0 hold · 1 sell
Ownershipinsiders 11.45% · institutions 76.88% · short 11.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for CORCEPT THERAPEUTICS INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
377 buys718 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Lyon Joseph Douglas | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lyon Joseph Douglas | Sell | $93.5K | SEC |
| Maduck Sean | Exercise | $3.4K | SEC |
| Maduck Sean | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Vieira Roberto Wandenkolk | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lyon Joseph Douglas | Sell | $514.4K | SEC |
| Lyon Joseph Douglas | Exercise | $112.3K | Unusual size | SEC |
| Lyon Joseph Douglas | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Vieira Roberto Wandenkolk | Sell | $126K | SEC |
| Maduck Sean | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lyon Joseph Douglas | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gunn Justin Frederick | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Vieira Roberto Wandenkolk | Sell | $241.4K | SEC |
| Lyon Joseph Douglas | Exercise | $11K | SEC |
| Lyon Joseph Douglas | Exercise | $45.5K | SEC |
| Maduck Sean | Sell | $1.8M | SEC |
| Vieira Roberto Wandenkolk | Exercise | $180.2K | SEC |
| Maduck Sean | Sell | $1M | SEC |
| Lyon Joseph Douglas | Sell | $552.9K | SEC |
| Vieira Roberto Wandenkolk | Sell | $600.1K | SEC |
| Maduck Sean | Exercise | $203.3K | SEC |
| Maduck Sean | Sell | $47.7K | SEC |
| Robb Gary Charles | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Robb Gary Charles | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Robb Gary Charles | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |